Literature DB >> 677271

Dose-dependent inhibition of experimental arterial thrombosis by carbenicillin and ticarcillin.

B T Lyman, G J Johnson, J G White.   

Abstract

An experimental model of canine arterial thrombosis was used to study by prophylactic antithrombotic effectiveness of carbenicillin and ticarcillin, two semisynthetic penicillins which have been shown to inhibit platelet function in vivo. Isolated peripheral arterial segments were injected with pronase and biopsied at 24 hours. In untreated dogs, 89% of injected segments totally occluded with thrombus. Prophylactic treatment for 3 to 7 days with carbenicillin or ticarcillin in low doses (250 mg/kg/day) or high doses 750 mg/kg/day) significantly decreased the incidence of total occlusion to 53% and 6%, respectively. The dose-dependent inhibition of arterial thrombosis correlated with dose-dependent inhibition of platelet function. Prophylactic treatment with aspirin in low doses (650 mg/day) or high doses (2600 mg/day) did not significantly decrease the incidence of total occlusion in this model. Carbenicillin and ticarcillin are effective experimental antithrombotic agents.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 677271      PMCID: PMC2018296     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  49 in total

1.  Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts).

Authors:  E Genton; M Gent; J Hirsh; L A Harker
Journal:  N Engl J Med       Date:  1975-12-18       Impact factor: 91.245

2.  THE AGGREGATION OF BLOOD PLATELETS.

Authors:  G V BORN; M J CROSS
Journal:  J Physiol       Date:  1963-08       Impact factor: 5.182

3.  A study of experimental methods for producing thrombosis in small arteries.

Authors:  H L DEATON; W G ANLYAN
Journal:  Surg Gynecol Obstet       Date:  1960-08

4.  Assay of proteolytic enzymes.

Authors:  N C DAVIS; E L SMITH
Journal:  Methods Biochem Anal       Date:  1955

Review 5.  Clinical pharmacology of platelets.

Authors:  M A Packham; J F Mustard
Journal:  Blood       Date:  1977-10       Impact factor: 22.113

6.  Arteriovenous-shunt thrombosis. Prevention by sulfinpyrazone.

Authors:  A Kaegi; G F Pineo; A Shimizu; H Trivedi; J Hirsh; M Gent
Journal:  N Engl J Med       Date:  1974-02-07       Impact factor: 91.245

Review 7.  Critical evaluation of platelet-inhibiting drugs in thrombotic disease.

Authors:  L A Harker; J Hirsh; M Gent; E Genton
Journal:  Prog Hematol       Date:  1975

8.  Effects of cephalothin and penicillin G on platelet function in vitro.

Authors:  M A Guccione; M A Packham; J F Mustard
Journal:  Br J Haematol       Date:  1977-01       Impact factor: 6.998

9.  Platelet dysfunction induced by parenteral carbenicillin and ticarcillin. Studies of the dose-response relationship and mechanism of action in dogs.

Authors:  G J Johnson; G H Rao; J G White
Journal:  Am J Pathol       Date:  1978-04       Impact factor: 4.307

10.  THE EFFECT OF SULFINPYRAZONE (ANTURAN) ON PLATELET ECONOMY AND BLOOD COAGULATION IN MAN.

Authors:  H A SMYTHE; M A OGRYZLO; E A MURPHY; J F MUSTARD
Journal:  Can Med Assoc J       Date:  1965-04-10       Impact factor: 8.262

View more
  1 in total

1.  Carbenicillin and penicillin G inhibit platelet function in vitro by impairing the interaction of agonists with the platelet surface.

Authors:  S J Shattil; J S Bennett; M McDonough; J Turnbull
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.